Effects of L-carnitine in patients with hepatic encephalopathy.
about
Acetyl-L-carnitine for patients with hepatic encephalopathyRole of carnitine in diseaseHyperammonemic encephalopathy caused by carnitine deficiency.Hepatic encephalopathy: a review of its pathophysiology and treatment.Review article: the current pharmacological therapies for hepatic encephalopathy.The treatment of hepatic encephalopathy.Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature.Pharmacotherapy for hepatic encephalopathy.Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients.Ammonia-lowering strategies for the treatment of hepatic encephalopathy.Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil.Current concepts in the pathophysiology and management of hepatic encephalopathy.Valproate-induced hyperammonemic encephalopathy, rapidly improved by i.v. carnitine and glucose/thiamine.Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.A Callosal Catastrophe: Toxic Leukoencephalopathy Associated with Thermogenic Weight Loss Supplement Use.Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients.
P2860
Q24187553-0A321E86-3C00-461C-911A-3F9998B1CD3AQ34618777-05DD7483-D58B-4FB8-9A50-0DA0A1234A53Q36607259-C433B46E-5AC4-486D-9AAE-502F3E5101C7Q36642901-8AD8F6F5-6D78-4252-9184-DCF91662AC14Q36734119-C95146E5-C438-43D7-BA9E-E4598D2F33C4Q36936857-71FC06D8-5058-4DC7-AA8D-3B712E642903Q37083352-EA9D408E-B40D-4799-A40A-6110A402AEFDQ37762245-7CA87407-E7D6-4C9C-B1E9-8D21724A3EDBQ37980384-59921E8A-A1C4-44F3-BEF1-092AA35DE09DQ38032730-E8B958B1-9540-48F0-8110-CE4C453DF6A3Q42283775-520E3A27-F240-4D5B-BC5D-DA29A5F6DD5BQ42781012-7C6A8A89-1F46-4428-9B50-58845A6D453AQ43159237-F6F85D24-6B7C-4429-9C2A-7FAA8B7F770AQ46689540-99589AA6-C3F1-4F23-A342-225B70C7876CQ47181235-93FDC7F2-F9FE-49E1-98A8-26CF7A33329BQ48886121-319887B8-9C5B-4073-9B75-2944001E8FD9Q48932150-9C63B61A-3FE7-40EB-AE09-D6BA8676B0F2Q50043583-650FE791-56E9-454D-8019-F45CB26CDF3AQ53790136-35C160E3-1159-4A73-8122-2D2D77EF77AD
P2860
Effects of L-carnitine in patients with hepatic encephalopathy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Effects of L-carnitine in patients with hepatic encephalopathy.
@ast
Effects of L-carnitine in patients with hepatic encephalopathy.
@en
type
label
Effects of L-carnitine in patients with hepatic encephalopathy.
@ast
Effects of L-carnitine in patients with hepatic encephalopathy.
@en
prefLabel
Effects of L-carnitine in patients with hepatic encephalopathy.
@ast
Effects of L-carnitine in patients with hepatic encephalopathy.
@en
P2093
P2860
P356
P1476
Effects of L-carnitine in patients with hepatic encephalopathy.
@en
P2093
Carmelo Leotta
Giovanni Pistone
Linda Scarpello
Mariano Malaguarnera
Rampello Elvira
Rampello Liborio
P2860
P304
P356
10.3748/WJG.V11.I45.7197
P407
P577
2005-12-01T00:00:00Z